Increased levels of cytokines, including tumor necrosis factor–α (TNF–α) and interleukin–6 (IL–6), reflect the rheumatoid synovial inflammation and have been shown to be associated with RA disease activity or response to anti–cytokine therapy [3, 4, 7, 8]. The gene discussed is TNF; the disease is rheumatoid arthritis.